Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000945040 | SCV001091024 | benign | Mucolipidosis type II; Pseudo-Hurler polydystrophy | 2024-10-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002545983 | SCV003595293 | likely benign | Inborn genetic diseases | 2021-12-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Diagnostics Division, |
RCV000945040 | SCV001338690 | likely benign | Mucolipidosis type II; Pseudo-Hurler polydystrophy | 2019-01-01 | no assertion criteria provided | research | |
Natera, |
RCV001276851 | SCV001463437 | uncertain significance | Mucolipidosis type II | 2020-04-17 | no assertion criteria provided | clinical testing |